Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients

The Egyptian Journal of Internal Medicine volume 29, pages 40–46 (2017)Cite this article

Abstract

Background and aim

Hepatocellular carcinoma (HCC) is the third cause of cancer-related mortality. α-fetoprotein (AFP) is not a highly sensitive marker for predicting HCC despite its high specificity. Serum Golgi protein-73 (sGP73) seems to be promising new marker. This study aimed at evaluating the role of sGP73 alone and in combination with AFP for diagnosing HCC.

Patients and methods

This study was conducted on 90 Egyptian patients who were equally divided into two groups. Group 1 included 45 patients with hepatitis C virus-related liver cirrhosis without clinical or radiological evidence of HCC, and group 2 included 45 patients diagnosed as having HCC by triphasic abdominal computed tomography. Serum AFP and GP73 were measured using enzyme-linked immunosorbent assay.

Results

A cutoff value greater than or equal to 40ng/ml for AFP had a sensitivity of 51.1%, specificity of 97.8%, and area under the curve (AUC) of 0.802. sGP73 with a cutoff value greater than or equal to 1.4 ng/ml yielded a sensitivity of 75.6%, specificity of 97.8%, diagnostic accuracy of 86.7%, and AUC of 0.908. The combined use of AFP and sGp73 led to an increase in sensitivity to 84.4%, specificity to 95.6%, diagnostic accuracy to 90%, and AUC to 0.947.

Conclusion

The combined use of AFP and sGp73 could increase the sensitivity and specificity for HCC diagnosis.

References

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557–2576.

    Article  CAS  Google Scholar 

  2. Harrison SA, Bacon BR. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention. Med Clin North Am 2005; 89: 391–409.

    Article  CAS  Google Scholar 

  3. Testino6 G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: a review and a point of view. World J Gastroenterol 2014; 20: 15943–15954.

    Article  CAS  Google Scholar 

  4. Mohamoud YA, Mumtaz GR, Riome S, Miller DW, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013; 13:288.

    Article  Google Scholar 

  5. Omar A, Abou-Alfa GK, Khairy A, Omar H. Risk factors for developing hepatocellular carcinoma in Egypt. Chin Clin Oncol 2013; 2:43.

    PubMed  Google Scholar 

  6. Kanwal F, El-Serag HB, Ross D. Surveillance for hepatocellular carcinoma: can we focus on the mission? Clin Gastroenterol Hepatol 2015; 13:805–807.

    Article  Google Scholar 

  7. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011; 4:5–10.

    Article  Google Scholar 

  8. Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging 2012; 12:530–547.

    Article  Google Scholar 

  9. Waidely E, Al-Yuobi AO, Bashammakh AS, El-Shahawi MS, Leblanc RM. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. Analyst 2016; 141:36–44.

    Article  CAS  Google Scholar 

  10. Ryder S. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52(Suppl 3):iii1–iii8.

  11. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 2005; 102:779–784.

    Article  CAS  Google Scholar 

  12. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005; 43:1007–1012.

    Article  CAS  Google Scholar 

  13. Hu JS, Wu DW, Liang S, Miao XY. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol 2010; 27:339–345.

    Article  CAS  Google Scholar 

  14. Yang J, Li J, Dai W, Wang F, Shen M, Chen K, et al. Golgi protein 73 as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. BMC Cancer 2015; 9:1413–1420.

    CAS  Google Scholar 

  15. Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut 2010; 59:1687–1693.

    Article  CAS  Google Scholar 

  16. Rahman El Zayadi A, Abaza H, Shawky S, Mohamed MK, Selim OE, Badran HM. Prevalence and epidemiological features of hepatocellular carcinoma in Egypt—a single center experience. Hepatol Res 2001; 19:170–179.

    Article  CAS  Google Scholar 

  17. Abdel-Wahab M, El-Ghawalby N, Mostafa M, El-Sadany M, Fathy O, Salah T, Ezzat F. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepatogastroenterology 2007; 54:157–162.

    PubMed  Google Scholar 

  18. El-Awady RR, Abdel-Aal IA, Hammad AM. Serum Golgi protein 73 in Egyptian patient with liver cirrhosis and hepatocellular carcinoma. AAMJ 2014; 12:186–203.

    Google Scholar 

  19. Dai M, Chen X, Liu X, Peng Z, Meng J, Dai S. Diagnostic value of the combination of Golgi protein 73 and alpha-fetoprotein in hepatocellular carcinoma: a meta-analysis. PLoS One 2015; 10:e0140067.

    Article  Google Scholar 

  20. Li X, Wu K, Fan D. Serum Golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma. Hepatology 2009; 50:325.

    Article  Google Scholar 

  21. Hou SC, Xiao MB, Ni RZ, Ni Wk, Jiang F, Li XY, et al. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. Oncol Lett 2013; 6:1152–1158.

    Article  CAS  Google Scholar 

  22. Shi Y, Chen J, Li L, Sun Z, Zen L, Xu S, et al. A study of diagnostic value of Golgi protein GP73 and its genetic assay in primary hepatic carcinoma. Technol Cancer Res Treat 2011; 10:287–294.

    Article  CAS  Google Scholar 

  23. Tian L, Wang Y, Xu D, Gui J, Jia X, Tong H, et al. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases. Int J Cancer 2011; 129:1923–1931.

    Article  CAS  Google Scholar 

  24. Hu B, Tian X, Sun J, Meng X. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Int J Mol Sci 2013; 14:23559–23580.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Department, Faculty of Medicine, Ain Shams University, Abbassia, Cairo, 11341, Egypt

    Mohamed M. Makhlouf, Mohamed Abdel Mabood, Shereen A. Saleh MD & Sarah El Nakeep

  2. Departments of Tropical Medicine, Ain Shams University, Cairo, Egypt

    Sara M. Abdelhakam

  3. Departments of Clinical and Chemical Pathology, Ain Shams University, Cairo, Egypt

    Marwa Rushdy

  4. Departments of Diagnostic Radiology, Diagnostic and Interventional Radiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Essam M. Abd-Al Hafez

  5. Department of Internal Medicine, Nasser Institute for Research and Treatment, Cairo, Egypt

    Ahmed Abbas

Authors
  1. Mohamed M. Makhlouf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Abdel Mabood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shereen A. Saleh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah El Nakeep
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sara M. Abdelhakam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marwa Rushdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Essam M. Abd-Al Hafez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ahmed Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shereen A. Saleh MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Makhlouf, M.M., Mabood, M.A., Saleh, S.A. et al. Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients. Egypt J Intern Med 29, 40–46 (2017). https://doi.org/10.4103/ejim.ejim_4_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_4_17

Keywords